Evaluation of intravenous fosfomycin disodium dosing regimens in critically ill patients for treatment of carbapenem-resistant enterobacterales infections using monte carlo simulation

16Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

There are limited intravenous fosfomycin disodium (IVFOS) dosing regimens to treat carbapenem-resistant Enterobacterales (CRE) infections. This study aimed to use Monte Carlo simulation (MCS) for evaluation of IVFOS dosing regimens in critically ill patients with CRE infections. The dosing regimens in critically ill patients with various creatinine clearance were evaluated with MCS using minimum inhibitory concentration (MIC) distributions of fosfomycin against CRE clinical isolates in Thailand and the 24 h area under the plasma drug concentration–time curve over the minimum inhibitory concentration (AUC0-24/MIC) of ≥21.5 to be a target for IVFOS. The achieved goal of the probability of target attainment (PTA) and a cumulative fraction of response (CFR) were ≥90%. A total of 129 non-duplicated CRE clinical isolates had MIC distributions from 0.38 to >1024 mg/L. IVFOS 8 g every 8 h, 1 h, or 4 h infusion, could achieve approximately 90% PTA of AUC0-24/MIC target to treat CRE infections with MICs ≤ 128 mg/L. According to PTA target, an IVFOS daily dose to treat carbapenem-resistant Escherichia coli based on Clinical Laboratory Standards Institute (CLSI) breakpoints for urinary tract infections and one to treatment for CRE infections based on the European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints were 16 g/day and 8 g/day, respectively. All dosing regimens of IVFOS against CRE achieved CFR ≤ 70%. This study proposes the IVFOS dosing regimens based on CLSI and EUCAST breakpoints for the treatment of CRE infections. However, further clinical studies are needed to confirm the results of these findings.

References Powered by Scopus

The epidemiology of Carbapenem-resistant enterobacteriaceae: The impact and evolution of a global menace

1107Citations
N/AReaders
Get full text

Treatment of infections caused by extended-spectrum-beta-lactamase-, ampC-, and carbapenemase-producing enterobacteriaceae

518Citations
N/AReaders
Get full text

Fosfomycin

446Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections

33Citations
N/AReaders
Get full text

Fosfomycin and nitrofurantoin: classic antibiotics and perspectives

18Citations
N/AReaders
Get full text

Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies

12Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Leelawattanachai, P., Wattanavijitkul, T., Paiboonvong, T., Plongla, R., Chatsuwan, T., Usayaporn, S., … Montakantikul, P. (2020). Evaluation of intravenous fosfomycin disodium dosing regimens in critically ill patients for treatment of carbapenem-resistant enterobacterales infections using monte carlo simulation. Antibiotics, 9(9), 1–14. https://doi.org/10.3390/antibiotics9090615

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

67%

Professor / Associate Prof. 1

11%

Lecturer / Post doc 1

11%

Researcher 1

11%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 3

50%

Medicine and Dentistry 2

33%

Nursing and Health Professions 1

17%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
Social Media
Shares, Likes & Comments: 163

Save time finding and organizing research with Mendeley

Sign up for free